Predictive modelling for high-risk stage II colon cancer using auto-artificial intelligence
暂无分享,去创建一个
Y. Nagakawa | M. Enomoto | T. Ishizaki | J. Mazaki | R. Udo | T. Tago | K. Kasahara
[1] G. Valentini,et al. Abdominal Computed Tomography Imaging Findings in Hospitalized COVID-19 Patients: A Year-Long Experience and Associations Revealed by Explainable Artificial Intelligence , 2021, J. Imaging.
[2] Y. Nagakawa,et al. A Novel Predictive Model for Anastomotic Leakage in Colorectal Cancer Using Auto-artificial Intelligence , 2021, AntiCancer Research.
[3] Y. Nagakawa,et al. A Novel Prediction Model for Colon Cancer Recurrence Using Auto-artificial Intelligence , 2021, AntiCancer Research.
[4] T. Rikiyama,et al. Oxaliplatin-Based Adjuvant Chemotherapy Duration (3 vs. 6 Months) for High-Risk Stage II Colon Cancer: The Randomized Phase 3 ACHIEVE-2 Trial. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] L. Beyer-Berjot,et al. Is Adjuvant Chemotherapy Necessary for Obstructing Stage II Colon Cancer? Results From a Propensity Score Analysis of the French Surgical Association Database , 2020, Annals of surgery.
[6] Masahiro Yoshida,et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer , 2019, International Journal of Clinical Oncology.
[7] Melissa Zhao,et al. Machine Learning With K-Means Dimensional Reduction for Predicting Survival Outcomes in Patients With Breast Cancer , 2018, Cancer informatics.
[8] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[9] N. Tomita,et al. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial. , 2018, European journal of cancer.
[10] M. Weiser,et al. AJCC 8th Edition: Colorectal Cancer , 2018, Annals of Surgical Oncology.
[11] Guigang Zhang,et al. Deep Learning , 2016, Int. J. Semantic Comput..
[12] Geoffrey E. Hinton,et al. Deep Learning , 2015, Nature.
[13] R. Labianca,et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] N. Tomita,et al. Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer , 2012, BMC Cancer.
[15] R. Greil,et al. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] C. Ko,et al. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.
[17] M. Somerfield,et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] H. Wieand,et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J. P. Pignon,et al. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators , 1995, The Lancet.